Mayukh Sukhatme - 20 Apr 2022 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)

Role
Pres & Chief Investment Officer
Signature
By: /s/ Jo Chen, as Attorney-in-Fact for Mayukh Sukhatme
Issuer symbol
ROIV
Transactions as of
20 Apr 2022
Transactions value $
$0
Form type
4
Filing time
22 Apr 2022, 19:31:32 UTC
Previous filing
01 Oct 2021
Next filing
31 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ROIV Stock Option (Right to Buy) Award $0 +16,523,184 $0 16,523,184 20 Apr 2022 Common Shares 16,523,184 $3.85 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award of stock options to purchase Common Shares with a vesting commencement date of April 20, 2022. These options vest and become exercisable (i) 25% on the first anniversary of the applicable vesting commencement date and (ii) in 36 equal monthly installments thereafter, subject generally to the reporting person's continuous service through each vesting date (unless otherwise provided in the applicable award documentation).

Remarks:

Pres & Chief Investment Officer